Publication Cover
Physiotherapy Theory and Practice
An International Journal of Physical Therapy
Volume 36, 2020 - Issue 9
148
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Clinical decision making and application of an active rehabilitation program for a person with the neuromuscular symptoms of Allgrove syndrome: a case report

Pages 1035-1042 | Received 10 Nov 2017, Accepted 28 Sep 2018, Published online: 03 Dec 2018

References

  • Allgrove J, Clayden GS, Grant DB, Macaulay JC. 1978. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet. 1(8077):1284–86.
  • Almhdawi KA, Mathiowetz VG, White M, delMas RC. 2016. Efficacy of occupational therapy task-oriented approach in upper extremity post-stroke rehabilitation. Occup Ther Int. 23:444–56.
  • Bassile C. 1996. Guillain-Barre syndrome and exercise guidelines. Neurol Rep. 20:31–36.
  • Bentes C, Santos-Bento M, de Sa J, de Lurdes Sales Luis M, de Carvalho M. 2001. Allgrove syndrome in adulthood. Muscle Nerve. 24:292–96.
  • Canalis E, Mazziotti G, Giustina A, Bilezikian JP. 2007. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporosis Int. 10:1319–28.
  • Cattaneo D, Jonsdottir J, Repetti S. 2007. Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil. 29:1920–25.
  • Cattaneo D, Regola A, Meotti M. 2006. Validity of six balance disorders scales in persons with multiple sclerosis. Disabil Rehabil. 28:789–95.
  • Clarkson HM. 2000. Musculoskeletal assessment; joint range of motion and manual muscle strength. Philadelphia, PA: Lippincott Williams and Wilkins.
  • Cronshaw JM, Matunis MJ. 2003. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proceedings of the National Academy of Sciences of the United States of America, New York, NY: The Rockefeller University; 100: 5823–27. doi:10.1073/pnas.1031047100.
  • Dal Bello-Haas V, Klassen L, Sheppard MS, Metcalfe A. 2011. Psychometric properties of activity, self-efficacy, and quality-of-life measures in individuals with Parkinson disease. Physiother Can. 63:47–57.
  • de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BC. 2009. Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporosis Int. 20:2111–25.
  • Dumic M, Barisic N, Kusec V, Stingl K, Skegro M, Stanimirovic A, Koehler K, Huebner A. 2012. Long-term clinical follow-up and molecular genetic findings in eight patients with triple A syndrome. Eur J Pediatr. 171:1453–59.
  • Dumic M, Barisic N, Rojnic-Putarek N, Kusec V, Stanimirovic A, Koehler K, Huebner A. 2011. Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy. Eur J Pediatr. 170:393–96.
  • Dusek T, Korsic M, Koehler K, Perkovic Z, Huebner A, Korsic M. 2006. A novel AAAS gene mutation (p.R194X) in a patient with triple A syndrome. Horm Res. 65:171–76.
  • Epstein S, Inzerillo AM, Caminis J, Zaidi M. 2003. Disorders associated with acute rapid and severe bone loss. J Bone Miner Res. 18:2083–94.
  • Ewing DJ, Neilson JM, Travis P. 1984. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. Br Heart J. 52::396–402.
  • Franchignoni F, Horak F, Godi M, Nardone A, Giordano A. 2010. Using psychometric techniques to improve the balance evaluation systems test: the mini-BESTest. J Rehabil Med. 42:323–31.
  • Gazarian M, Cowell CT, Bonney M, Grigor WG. 1995. The “4A” syndrome: adrenocortical insufficiency associated with achalasia, alacrima, autonomic and other neurological abnormalities. Eur J Pediatr. 154:18–23.
  • Gilio F, Di Rezze S, Conte A, Frasca V, Iacovelli E, Marini Bettolo C, Gabriele M, Giacomelli E, Pizzuti A, Pirro C, et al. 2007. Case report of adult-onset allgrove syndrome. Neurol Sci. 28:331–35.
  • Godi M, Franchignoni F, Caligari M, Giordano A, Turcato AM, Nardone A. 2013. Comparison of reliability, validity, and responsiveness of the mini-BESTest and berg balance scale in patients with balance disorders. Phys Ther. 93:158–67.
  • Goizet C, Catargi B, Tison F, Tullio-Pelet A, Hadj-Rabia S, Pujol F, Lagueny A, Lyonnet S, Lacombe D. 2002. Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology. 58:962–65.
  • Goldman MD, Marrie RA, Cohen JA. 2008. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Multiple Sclerosis. 14:383–90.
  • Grant DB, Barnes ND, Dumic M, Ginalska-Malinowska M, Milla PJ, von Petrykowski W, Werder E. 1993. Neurological and adrenal dysfunction in the adrenal insufficiency/alacrima/achalasia (3A) syndrome. Arch Dis Child. 68:779–82.
  • Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. 2001. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet. 10:283–90.
  • Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. 2006. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proceedings of the National Academy of Sciences of the United States of America, St. Louis, MO: Saint Louis University School of Medicine; 103: 2298–303. doi:10.1073/pnas.0505598103.
  • Houlden H, Smith S, De Carvalho M, Blake J, Mathias C, Wood NW, Reilly MM. 2002. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain. 125(Pt 12):2681–90.
  • Ismail EA, Tulliot-Pelet A, Mohsen AM, Al-Saleh Q. 2006. Allgrove syndrome with features of familial dysautonomia: a novel mutation in the AAAS gene. Acta Paediatr. 95:1140–43.
  • Kimber J, McLean BN, Prevett M, Hammans SR. 2003. Allgrove or 4 “A” syndrome: an autosomal recessive syndrome causing multisystem neurological disease. J Neurol Neurosurg Psychiatry. 74:654–57.
  • Koehler K, Brockmann K, Krumbholz M, Kind B, Bonnemann C, Gartner J, Huebner A. 2008. Axonal neuropathy with unusual pattern of amyotrophy and alacrima associated with a novel AAAS mutation p.Leu430Phe. Eur J Hum Genet. 16:1499–506.
  • Krumbholz M, Koehler K, Huebner A. 2006. Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutation. Biochem Cell Biol. 84:243–49.
  • Lam YY, Lo IF, Shek CC, Tong TM, Ng DK, Tong TF, Choi MS, Lam ST, Ho CS. 2006. Triple-A syndrome–the first Chinese patient with novel mutations in the AAAS gene. J Pediatr Endocrinol Metab. 19:765–70.
  • McKeever PE, Camelo-Piragua S, Dowling J. 2012. External and internal influences on muscle pathology. Arch Pathol Lab Med. 136:927–34.
  • Milenkovic T, Zdravkovic D, Savic N, Todorovic S, Mitrovic K, Koehler K, Huebner A. 2010. Triple A syndrome: 32 years experience of a single centre (1977-2008). Eur J Pediatr. 169:1323–28.
  • Miyahara M, Hillier SL, Pridham L, Nakagawa S. 2017. Task-oriented interventions for children with developmental co-ordination disorder. Cochrane Database Syst Rev. 7:CD010914.
  • Palka C, Giuliani R, Brancati F, Mohn A, Di Muzio A, Calabrese O, Huebner A, De Grandis D, Chiarelli F, Ferlini A, et al. 2010. Two Italian patients with novel AAAS gene mutation expand allelic and phenotypic spectrum of triple A (Allgrove) syndrome. Clin Genet. 77:298–301.
  • Perera S, Mody SH, Woodman RC, Studenski SA. 2006. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 54:743–49.
  • Prpic I, Huebner A, Persic M, Handschug K, Pavletic M. 2003. Triple A syndrome: genotype-phenotype assessment. Clin Genet. 63:415–17.
  • Qin K, Du X, Rich BH. 2007. An Alu-mediated rearrangement causing a 3.2kb deletion and a novel two base pair deletion in AAAS gene as the cause of triple A syndrome. Mol Genet Metab. 92:359–63.
  • Reimann J, Kohlschmidt N, Tolksdorf K, Weis J, Kuchelmeister K, Roos A. 2017. Muscle pathology as a diagnostic clue to allgrove syndrome. J Neuropathol Exp Neurol. 76:337–41.
  • Schneiberg S, McKinley PA, Sveistrup H, Gisel E, Mayo NE, Levin MF. 2010. The effectiveness of task-oriented intervention and trunk restraint on upper limb movement quality in children with cerebral palsy. Dev Med Child Neurol. 52:e245–253.
  • Speth L, Janssen-Potten Y, Rameckers E, Defesche A, Winkens B, Becher J, Vles H. 2015. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity activities in unilateral Cerebral Palsy: A clinical trial. BMC Neurol. 15:143.
  • Strauss M, Koehler K, Krumbholz M, Huebner A, Zierz S, Deschauer M. 2008. Triple A syndrome mimicking ALS. Amyotrophic Lateral Sclerosis. 9:315–17.
  • Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G. 2008. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve. 38:964–71.
  • Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C, et al. 2000. Mutant WD-repeat protein in triple-A syndrome. Nat Genet. 26:332–35.
  • Vallet AE, Verschueren A, Petiot P, Vandenberghe N, Nicolino M, Roman S, Vial C. 2012. Neurological features in adult triple-A (allgrove) syndrome. J Neurol. 259:39–46.
  • Villanueva-Mendoza C, Martinez-Guzman O, Rivera-Parra D, Zenteno JC. 2009. Triple A or allgrove syndrome. A case report with ophthalmic abnormalities and a novel mutation in the AAAS gene. Ophthalmic Genet. 30:45–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.